outcomeCategory,disease,model,comparison,database,nTNF,nComparator,HazardRatio,RobustWaldLower,RobustWaldUpper,indValidHR,indSigHR
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,537,139,59128.197006,8253.0010417,423620.89421,0,0
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2817,708,0.1866260932,0.0542245269,0.6423163219,1,1
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,700,533,1.5687980397,0.7196055578,3.4201060048,1,0
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,0.3036729858,0.0340277416,2.7100617915,1,0
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2817,2648,0.3162567454,0.1132644176,0.8830516332,1,1
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,700,1906,1.7486222574,1.012713619,3.01929365,1,1
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs DMARD,MPCD,537,139,35152.259984,4871.1665555,253672.57881,0,0
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2817,708,0.1897572298,0.0506983058,0.7102368754,1,1
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs DMARD,Medicare,700,533,1.5750749211,0.6968948081,3.5598787339,1,0
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,0.2489338922,0.0276759415,2.2390596057,1,0
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2817,2648,0.2307224016,0.0728340472,0.7308783278,1,1
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,700,1906,1.7980047266,1.0037457764,3.2207567622,1,1
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,537,139,14361.812276,1986.5838147,103827.30913,0,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2817,708,0.2005405206,0.053652932,0.7495676171,1,1
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,700,533,1.7490995659,0.7740699147,3.9522906564,1,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,537,663,0.2451747491,0.0272372137,2.2069312364,1,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2817,2648,0.2266127704,0.0711417775,0.7218451593,1,1
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,700,1906,1.7486755403,0.9711496942,3.1487073141,1,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,537,139,35065.916408,4856.3904046,253195.97295,0,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2817,708,0.1820061456,0.0488544271,0.6780600867,1,1
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,700,533,1.4932360629,0.6570002214,3.3938404692,1,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,537,663,0.2454125867,0.0272940923,2.2066070942,1,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2817,2648,0.2312502899,0.0730344001,0.7322124433,1,1
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,700,1906,1.7937417213,1.0011289366,3.2138810949,1,1
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,537,139,35131.984158,4867.1604759,253588.57941,0,0
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2817,708,0.1875366725,0.0501070073,0.7018979071,1,1
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,700,533,1.5201996993,0.677755959,3.4097924113,1,0
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,537,663,0.249609555,0.0277504993,2.245182303,1,0
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2817,2648,0.2318123853,0.0731698974,0.7344137948,1,1
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,700,1906,1.7883268099,0.9993365176,3.2002360793,1,0
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,537,139,38820.55397,5364.6667765,280918.73612,0,0
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,2817,708,0.1918430089,0.0514498996,0.7153316207,1,1
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,700,533,1.6278799234,0.7185610505,3.6879163474,1,0
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,537,663,0.2406698294,0.0267586049,2.1646108588,1,0
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,2817,2648,0.2272870535,0.0713849977,0.7236731294,1,1
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,700,1906,1.743275567,0.9710329147,3.1296670345,1,0
Cancer,Hematologic Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,537,139,23174.417322,3219.1720791,166829.73293,0,0
Cancer,Hematologic Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2817,708,0.1999869128,0.0539449547,0.7413995521,1,1
Cancer,Hematologic Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,700,533,1.7687159536,0.7827817346,3.9964602986,1,0
Cancer,Hematologic Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,537,663,0.2434146329,0.0270181669,2.1929942084,1,0
Cancer,Hematologic Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2817,2648,0.224242361,0.0705818064,0.7124305688,1,1
Cancer,Hematologic Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,700,1906,1.7447757485,0.9688754945,3.1420367526,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,537,139,1.1021763525,0.2416574559,5.0269200572,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2819,710,0.6199713563,0.3154155396,1.2185971658,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,702,537,1.1988248333,0.8023506116,1.7912131681,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,1.2035901807,0.5016058683,2.8879832046,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2819,2651,1.2566667454,0.7476845235,2.1121358798,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,702,1920,1.0441900373,0.8076392269,1.3500246121,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs DMARD,MPCD,537,139,1.7995601159,0.3691863193,8.7717676448,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2819,710,0.6764060228,0.3148818095,1.4530058383,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs DMARD,Medicare,702,537,1.1896629896,0.7613145782,1.8590186886,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,2.3367396474,0.884297038,6.1747941527,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2819,2651,1.295241729,0.6878261908,2.4390625992,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,702,1920,1.0162206897,0.7553390123,1.3672066097,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,537,139,1.9397769085,0.3992561058,9.4243629594,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2819,710,0.7235630464,0.3344199563,1.5655270337,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,702,537,1.2987105734,0.8370759484,2.0149296569,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,537,663,2.3026809748,0.8705893572,6.0905174496,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2819,2651,1.2883168294,0.6816753251,2.4348251898,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,702,1920,0.9970635121,0.7404805239,1.3425547534,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,537,139,1.7881338839,0.3670035461,8.7122394894,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2819,710,0.6239197408,0.2907292896,1.3389632791,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,702,537,1.0767748975,0.6897669362,1.680921655,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,537,663,2.2881514685,0.864525427,6.0560823078,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2819,2651,1.3018888118,0.6914937777,2.4510914385,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,702,1920,1.0169736555,0.7539600188,1.3717377449,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,537,139,1.8224629686,0.3737411227,8.886823177,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2819,710,0.6857851719,0.3192147936,1.4733067244,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,702,537,1.2314038098,0.7784185574,1.9479948523,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,537,663,2.3294636099,0.881457836,6.1561659429,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2819,2651,1.2890728948,0.6847391541,2.4267765588,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,702,1920,1.025180764,0.759535553,1.383734566,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,537,139,1.9610262725,0.4040074655,9.5186954929,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,2819,710,0.6813284849,0.3153931585,1.4718407547,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,702,537,1.2143489421,0.77722899,1.8973087367,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,537,663,2.2376472962,0.8449591628,5.9258075924,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,2819,2651,1.2880676273,0.6825022292,2.430934496,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,702,1920,1.0121491726,0.7484791282,1.3687034266,1,0
Cancer,Non Melanoma Skin Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,537,139,1.89031992,0.3898440233,9.1659976452,1,0
Cancer,Non Melanoma Skin Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2819,710,0.7140612918,0.3303316803,1.5435501914,1,0
Cancer,Non Melanoma Skin Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,702,537,1.2876242289,0.8277954814,2.0028813784,1,0
Cancer,Non Melanoma Skin Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,537,663,2.2781425438,0.8612539962,6.0260195867,1,0
Cancer,Non Melanoma Skin Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2819,2651,1.2754032762,0.6749579819,2.4100070828,1,0
Cancer,Non Melanoma Skin Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,702,1920,0.9935300479,0.7371819756,1.3390207422,1,0
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,530,136,0.75237939,0.2084023215,2.7162593124,1,0
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2791,683,0.6507917822,0.3667201286,1.1549132726,1,0
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,647,474,0.8007600159,0.5676650146,1.129568648,1,0
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,530,658,0.3864995024,0.1901782299,0.7854835195,1,1
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2791,2616,0.5921253992,0.4163714234,0.8420666467,1,1
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,647,1814,0.6493758767,0.5050995403,0.8348632213,1,1
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs DMARD,MPCD,530,136,0.8861918059,0.2315090425,3.3922472679,1,0
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2791,683,0.8728174127,0.4194004845,1.8164266948,1,0
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs DMARD,Medicare,647,474,0.9294077086,0.6388077793,1.3522043981,1,0
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,530,658,0.380093887,0.1727984232,0.8360687571,1,1
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2791,2616,0.7277631551,0.4615577954,1.1475035525,1,0
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,647,1814,0.7501328258,0.5644848574,0.9968367599,1,1
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,530,136,0.8815637176,0.2294777958,3.3866221577,1,0
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2791,683,0.8718374128,0.4202770251,1.8085701309,1,0
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,647,474,0.9286885007,0.6423518508,1.3426634177,1,0
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,530,658,0.3811368315,0.1733331957,0.8380696137,1,1
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2791,2616,0.7307581532,0.462205434,1.1553466039,1,0
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,647,1814,0.7515194361,0.5642900771,1.0008708036,1,0
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,530,136,0.8857954292,0.2311698663,3.3941860809,1,0
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2791,683,0.8341546106,0.40084255,1.7358783749,1,0
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,647,474,0.8656277439,0.5947242765,1.2599307288,1,0
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,530,658,0.37487317,0.1701793639,0.8257751723,1,1
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2791,2616,0.7295473751,0.4628810065,1.1498405963,1,0
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,647,1814,0.7490990187,0.5635438537,0.9957509713,1,1
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,530,136,0.8784547812,0.2294754987,3.3628113106,1,0
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2791,683,0.8697527336,0.4182622818,1.8086015656,1,0
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,647,474,0.9101687154,0.6251996264,1.3250281278,1,0
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,530,658,0.3807668408,0.1730980727,0.8375794417,1,1
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2791,2616,0.7305668943,0.4633327166,1.1519324406,1,0
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,647,1814,0.7487650158,0.5635724691,0.9948126986,1,1
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,530,136,0.8827974854,0.2294951501,3.3958512845,1,0
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,2791,683,0.8355267896,0.4027903036,1.733172348,1,0
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,647,474,0.8545426496,0.589654812,1.2384247955,1,0
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,530,658,0.3757078429,0.1706348002,0.8272426437,1,1
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,2791,2616,0.733053445,0.4639018448,1.1583643377,1,0
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,647,1814,0.7485039908,0.5623609365,0.9962609203,1,1
Cancer,Solid Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,530,136,0.8691738187,0.2256409903,3.3480757459,1,0
Cancer,Solid Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2791,683,0.8634677553,0.4172454585,1.7869015689,1,0
Cancer,Solid Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,647,474,0.9269374252,0.6397431954,1.3430592094,1,0
Cancer,Solid Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,530,658,0.3799577941,0.1728234662,0.8353490901,1,1
Cancer,Solid Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2791,2616,0.7293548218,0.4596963934,1.1571951917,1,0
Cancer,Solid Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,647,1814,0.7485207064,0.5614139525,0.9979859698,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,533,139,1.1203789632,0.1310880791,9.5756153375,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2801,705,0.5914806213,0.2365613891,1.4788944496,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,672,511,1.2541072146,0.8117630113,1.9374926966,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,533,662,0.5443263893,0.1891226675,1.5666615857,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2801,2643,0.7845312341,0.4190150018,1.468895516,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,672,1875,0.8351251577,0.6207585274,1.1235190468,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs DMARD,MPCD,533,139,3.9768985748,0.4028970661,39.2549949,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2801,705,1.1064629968,0.4017090306,3.0476296777,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs DMARD,Medicare,672,511,1.2836774195,0.7995783729,2.0608707956,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,533,662,1.6578170137,0.4302725486,6.3874798891,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2801,2643,0.8175429045,0.3678455722,1.8170027074,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,672,1875,0.9351441273,0.6728933205,1.2996035363,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,533,139,3.9209361543,0.3990306161,38.527721193,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2801,705,1.0988953958,0.3998602603,3.0199827559,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,672,511,1.2727686984,0.7978368842,2.0304152285,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,533,662,1.6657991477,0.4311963886,6.4353201323,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2801,2643,0.8243076376,0.3693351809,1.8397464326,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,672,1875,0.9402757585,0.6724955795,1.3146829941,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,533,139,3.9589595057,0.40237773,38.951858412,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2801,705,1.048666844,0.3817963911,2.8803366801,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,672,511,1.1977304115,0.7453105967,1.9247789378,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,533,662,1.6247321206,0.4223044313,6.2508329737,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2801,2643,0.8208143359,0.3695613479,1.8230699121,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,672,1875,0.9327270795,0.670748133,1.2970290367,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,533,139,3.9796110217,0.4031605594,39.282870098,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2801,705,1.1072154354,0.4019929692,3.0496205517,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,672,511,1.2869337476,0.8005475329,2.0688321463,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,533,662,1.6575243958,0.4301885139,6.3864725209,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2801,2643,0.8173114149,0.3674138308,1.8181077927,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,672,1875,0.9357190146,0.6735451532,1.2999426543,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,533,139,3.9390779438,0.4019093622,38.606552884,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,2801,705,1.0459853021,0.3815221866,2.867684477,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,672,511,1.1951521356,0.7460011191,1.914727191,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,533,662,1.62985857,0.4225306728,6.2869730625,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,2801,2643,0.8254016571,0.3700195085,1.8412215568,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,672,1875,0.9371887261,0.6708776995,1.3092143456,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,533,139,3.66797315,0.3782571556,35.568466663,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2801,705,1.0500957209,0.3850186809,2.8640195339,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,672,511,1.2309248516,0.7686404786,1.9712414745,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,533,662,1.6515696471,0.4306465707,6.3339231857,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2801,2643,0.8152245625,0.3663348905,1.8141626817,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,672,1875,0.9438789502,0.6742784096,1.321275396,1,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,537,139,34928.067918,8667.9253373,140745.32037,0,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2805,704,1.0230173421,0.3526873204,2.9674003626,1,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,680,518,0.9377628605,0.6102437431,1.4410621861,1,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,0.2666100233,0.0578808631,1.2280553673,1,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2805,2645,0.5282326776,0.3094025723,0.9018340072,1,1
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,680,1881,0.7844862553,0.5740772532,1.0720137077,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs DMARD,MPCD,537,139,17805.942462,4195.038485,75577.75408,0,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2805,704,1.6307944001,0.4906845468,5.4199595088,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs DMARD,Medicare,680,518,1.0314973449,0.6351297891,1.6752273171,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,0.1804317807,0.0373554023,0.8715105577,1,1
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2805,2645,0.9630146674,0.453361018,2.045604304,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,680,1881,0.843133316,0.5810525547,1.2234242544,1,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,537,139,18147.341669,4263.7132627,77239.248831,0,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2805,704,1.6574886887,0.502121705,5.4713204498,1,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,680,518,1.0543163276,0.6588271135,1.6872148944,1,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,537,663,0.1798303823,0.0372360257,0.8684859843,1,1
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2805,2645,0.960319056,0.4492383168,2.0528362225,1,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,680,1881,0.8383607754,0.5726919577,1.2272719744,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,537,139,17863.038365,4190.6292084,76143.2529,0,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2805,704,1.5311379762,0.4597420656,5.0993452145,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,680,518,0.954854873,0.5890855158,1.5477342492,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,537,663,0.1769108181,0.0365232031,0.8569192987,1,1
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2805,2645,0.9655283465,0.4550318358,2.0487467347,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,680,1881,0.8387292681,0.5782767772,1.2164880431,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,537,139,6820.5480587,1606.9822749,28948.592991,0,0
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2805,704,1.6577173176,0.4972840089,5.5260709288,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,680,518,1.0680664732,0.6520832633,1.7494176822,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,537,663,0.1797275958,0.0372075091,0.8681583218,1,1
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2805,2645,0.9568425629,0.4520647669,2.0252577886,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,680,1881,0.8484740541,0.5842721339,1.2321453971,1,0
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,537,139,6947.038727,1626.5018151,29671.867947,0,0
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,2805,704,1.5898608075,0.4793875496,5.272680505,1,0
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,680,518,1.0097492774,0.6274843887,1.6248907887,1,0
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,537,663,0.1754928425,0.0362382998,0.8498670739,1,1
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,2805,2645,0.9583414326,0.450602971,2.0381985039,1,0
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,680,1881,0.8389015074,0.5739950781,1.2260658076,1,0
Cardiac disease,Conduction Block,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,537,139,23469.443842,5501.2056095,100126.19658,0,0
Cardiac disease,Conduction Block,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2805,704,1.5894586426,0.4904564777,5.1510763779,1,0
Cardiac disease,Conduction Block,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,680,518,1.0330527365,0.6421883809,1.6618144895,1,0
Cardiac disease,Conduction Block,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,537,663,0.1778788576,0.0368506625,0.8586246705,1,1
Cardiac disease,Conduction Block,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2805,2645,0.9428442848,0.4469270076,1.9890392174,1,0
Cardiac disease,Conduction Block,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,680,1881,0.835183843,0.5691473593,1.2255737293,1,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,537,139,455325.48897,144991.09969,1429889.8439,0,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2817,709,1.4611146009,0.1827173112,11.683927831,1,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,695,530,0.9278194773,0.4778861147,1.8013684766,1,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,442275.37303,142646.59382,1371273.5814,0,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2817,2648,0.9237878155,0.3353543155,2.544723263,1,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,695,1908,0.8325041057,0.5099596557,1.3590547375,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs DMARD,MPCD,537,139,805246.68268,233737.15133,2774151.2904,0,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2817,709,0.6661926578,0.0823662626,5.3882820895,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs DMARD,Medicare,695,530,1.3828287452,0.671448338,2.8478964507,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,778249.43757,226743.34762,2671179.5227,0,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2817,2648,0.7945022901,0.277598297,2.2739112448,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,695,1908,1.1068888191,0.6286905268,1.9488171138,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,537,139,811842.02739,237214.23496,2778448.256,0,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2817,709,0.6671330297,0.0815022467,5.4607878562,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,695,530,1.4272729931,0.7045836339,2.8912227007,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,537,663,800622.09092,232190.7398,2760642.9655,0,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2817,2648,0.7935833681,0.2777332498,2.2675519137,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,695,1908,1.1054644073,0.6184318551,1.9760488495,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,537,139,801314.38626,230239.81397,2788851.9129,0,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2817,709,0.6305164273,0.078288474,5.0780267457,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,695,530,1.2801534302,0.6214129188,2.6372042731,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,537,663,767464.92423,220914.27995,2666203.4254,0,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2817,2648,0.7974887593,0.2787586909,2.2815013195,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,695,1908,1.100599482,0.62434771,1.9401356014,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,537,139,976814.85275,283517.77965,3365458.2712,0,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2817,709,0.689995528,0.0850969367,5.5947234635,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,695,530,1.503507188,0.7011050859,3.2242439968,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,537,663,1078840.2785,314311.32792,3703004.77,0,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2817,2648,0.7818905931,0.2728376775,2.2407202154,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,695,1908,1.1271203383,0.6355915822,1.9987682224,1,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,537,139,974705.77149,283142.6508,3355380.5415,0,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,2817,709,0.6598769178,0.0805807284,5.4037429985,1,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,695,530,1.421253776,0.6809464253,2.966404141,1,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,537,663,1101822.8546,315553.49097,3847251.3775,0,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,2817,2648,0.7876150568,0.2754732992,2.2518969333,1,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,695,1908,1.1196932925,0.6211305615,2.0184372611,1,0
Cardiac disease,Myocardial infarction,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,537,139,1103186.8872,334909.06157,3633885.8745,0,0
Cardiac disease,Myocardial infarction,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2817,709,0.6401671837,0.077702949,5.2741115784,1,0
Cardiac disease,Myocardial infarction,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,695,530,1.4016849558,0.6893640015,2.8500483213,1,0
Cardiac disease,Myocardial infarction,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,537,663,1116415.3004,326144.91558,3821562.3286,0,0
Cardiac disease,Myocardial infarction,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2817,2648,0.7839644664,0.2752282478,2.2330567067,1,0
Cardiac disease,Myocardial infarction,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,695,1908,1.1061172835,0.6185303389,1.9780686054,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,537,139,4.7054154186,0.6369659593,34.759996102,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2819,710,0.9032975039,0.6413950327,1.2721432798,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,702,537,0.872511524,0.6919636907,1.100168072,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,1.4988345438,0.7920976836,2.8361463949,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2819,2651,1.1551706578,0.9321710894,1.4315175228,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,702,1920,0.9370953089,0.788202225,1.1141146144,1,0
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs DMARD,MPCD,537,139,13.186985674,1.6779132652,103.63860562,1,1
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2819,710,0.7670006694,0.4994125081,1.1779641424,1,0
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs DMARD,Medicare,702,537,0.9150626583,0.7103421143,1.1787836477,1,0
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,3.7076947348,1.630595142,8.4306642968,1,1
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2819,2651,1.1431353521,0.8853437214,1.4759899479,1,0
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,702,1920,0.9652086937,0.7943025487,1.1728878672,1,0
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,537,139,14.047758512,1.7911758749,110.17316724,1,1
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2819,710,0.8032496851,0.5205880038,1.2393871007,1,0
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,702,537,0.9917751788,0.7749091782,1.2693332753,1,0
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,537,663,3.6617647038,1.6065631649,8.3460899883,1,1
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2819,2651,1.1300222513,0.8728410228,1.4629815224,1,0
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,702,1920,0.9376605329,0.7709667896,1.140395782,1,0
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,537,139,13.186263712,1.6781428474,103.61308094,1,1
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2819,710,0.7685734389,0.4990827666,1.1835815029,1,0
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,702,537,0.9172860723,0.7120818116,1.1816250952,1,0
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,537,663,3.70937693,1.630708041,8.4377318705,1,1
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2819,2651,1.1430171058,0.8852825071,1.4757866485,1,0
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,702,1920,0.9653755841,0.7945217691,1.172969772,1,0
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,537,139,13.566447289,1.7238475331,106.76610808,1,1
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2819,710,0.7889184707,0.5118381311,1.2159945022,1,0
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,702,537,0.9802444918,0.7572855493,1.2688466915,1,0
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,537,663,3.685242666,1.6204545746,8.3809899522,1,1
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2819,2651,1.1287849511,0.8753233885,1.45563969,1,0
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,702,1920,0.9775874206,0.8045698269,1.1878113408,1,0
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,537,139,14.190614018,1.8074103901,111.41549662,1,1
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,2819,710,0.8182433458,0.527300525,1.2697164923,1,0
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,702,537,1.0373523401,0.8054005346,1.3361052436,1,0
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,537,663,3.6504312436,1.600870203,8.3240029323,1,1
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,2819,2651,1.1202147982,0.8668357919,1.447657337,1,0
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,702,1920,0.9495880695,0.7804754783,1.1553437961,1,0
Infection,Hospitalized infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,537,139,13.801000506,1.7615229904,108.12666993,1,1
Infection,Hospitalized infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2819,710,0.7902293387,0.5130417843,1.2171765084,1,0
Infection,Hospitalized infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,702,537,0.9732749558,0.7591605787,1.2477783571,1,0
Infection,Hospitalized infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,537,663,3.6623318301,1.6052532533,8.3554880866,1,1
Infection,Hospitalized infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2819,2651,1.1278331614,0.8713368343,1.4598345783,1,0
Infection,Hospitalized infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,702,1920,0.942148851,0.7747525826,1.1457134541,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,537,139,0.4228636006,0.106630676,1.6769435535,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2819,710,0.688856177,0.3981648603,1.1917747643,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,702,537,0.9871642561,0.614387964,1.5861203761,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,1.8209785727,0.5131054017,6.4625376219,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2819,2651,1.5380927878,1.0037854113,2.3568079366,1,1
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,702,1920,0.8624695625,0.6100978444,1.2192368046,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs DMARD,MPCD,537,139,0.3656126782,0.0877395195,1.5235167829,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2819,710,0.6874304328,0.3749874924,1.2602036321,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs DMARD,Medicare,702,537,0.9121430348,0.5416610101,1.5360251162,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,1.291162966,0.3460024216,4.8181795878,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2819,2651,0.7907553619,0.4428380177,1.4120152682,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,702,1920,0.7766162208,0.5275829308,1.1431999013,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,537,139,0.4154996782,0.0988243912,1.7469369713,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2819,710,0.7399522294,0.4008838419,1.3658053644,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,702,537,1.0486357145,0.6166366922,1.7832815915,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,537,663,1.2572058312,0.3366284457,4.6952850312,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2819,2651,0.7749653557,0.4342590261,1.3829794347,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,702,1920,0.7547390748,0.5121693252,1.1121928686,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,537,139,0.3701649143,0.0889416355,1.5405840366,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2819,710,0.7206901148,0.3912804757,1.3274218212,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,702,537,0.9727470767,0.5770474851,1.6397903113,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,537,663,1.3144585499,0.3521849789,4.9059482454,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2819,2651,0.7890137306,0.4426812375,1.4063000968,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,702,1920,0.7801201048,0.530043232,1.1481844143,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,537,139,0.3689522817,0.0885111062,1.5379514737,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2819,710,0.6934369616,0.3789459654,1.2689271387,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,702,537,0.9366576785,0.5577379947,1.5730102934,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,537,663,1.2883518685,0.3452444301,4.8077547161,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2819,2651,0.7868769308,0.4406167657,1.4052468093,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,702,1920,0.781705512,0.5311728066,1.1504043502,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,537,139,0.4197101809,0.099773342,1.7655681611,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,2819,710,0.7674521526,0.4149303049,1.4194740651,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,702,537,1.1104361924,0.6539519004,1.8855645754,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,537,663,1.2807287045,0.342661331,4.7868430612,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,2819,2651,0.7740392479,0.4348317296,1.377858874,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,702,1920,0.7579125559,0.5140301717,1.1175053023,1,0
Infection,Opportunistic infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,537,139,0.4086206106,0.097359639,1.7149899594,1,0
Infection,Opportunistic infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2819,710,0.7329211192,0.396653064,1.3542650135,1,0
Infection,Opportunistic infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,702,537,1.0567531179,0.6207051088,1.7991267293,1,0
Infection,Opportunistic infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,537,663,1.2568247529,0.3363325368,4.6965674941,1,0
Infection,Opportunistic infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2819,2651,0.7722803657,0.4325045547,1.3789842367,1,0
Infection,Opportunistic infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,702,1920,0.7535748507,0.5110060859,1.1112882436,1,0
Inflammatory bowel disease,Crohns Disease,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,515,132,2.9584308503,0.3896211671,22.463648887,1,0
Inflammatory bowel disease,Crohns Disease,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2723,688,1.2323052303,0.6333023421,2.3978692004,1,0
Inflammatory bowel disease,Crohns Disease,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,674,520,2.1162648294,0.8979858135,4.9873581084,1,0
Inflammatory bowel disease,Crohns Disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,515,657,1.2482071774,0.57799807,2.6955473357,1,0
Inflammatory bowel disease,Crohns Disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2723,2615,1.2585148445,0.8579242402,1.8461532378,1,0
Inflammatory bowel disease,Crohns Disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,674,1895,1.4967847444,0.8836621784,2.535317937,1,0
Inflammatory bowel disease,Crohns Disease,"a Weighted, no covariates",TNF vs DMARD,MPCD,515,132,4.2161105286,0.5369676593,33.103647269,1,0
Inflammatory bowel disease,Crohns Disease,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2723,688,1.0537595683,0.4534425573,2.448842108,1,0
Inflammatory bowel disease,Crohns Disease,"a Weighted, no covariates",TNF vs DMARD,Medicare,674,520,1.952357218,0.7796546798,4.8889576442,1,0
Inflammatory bowel disease,Crohns Disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,515,657,1.2170848431,0.5098607513,2.9052942624,1,0
Inflammatory bowel disease,Crohns Disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2723,2615,1.2066084068,0.7708709973,1.8886478445,1,0
Inflammatory bowel disease,Crohns Disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,674,1895,1.3649521494,0.7612638706,2.4473700145,1,0
Inflammatory bowel disease,Crohns Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,515,132,4.1392673757,0.5243157951,32.677891013,1,0
Inflammatory bowel disease,Crohns Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2723,688,1.0348083327,0.4420239512,2.4225571544,1,0
Inflammatory bowel disease,Crohns Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,674,520,1.9900129296,0.8069658948,4.9074582772,1,0
Inflammatory bowel disease,Crohns Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,515,657,1.2275121586,0.5138110063,2.932568748,1,0
Inflammatory bowel disease,Crohns Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2723,2615,1.2196631041,0.7783610148,1.9111672594,1,0
Inflammatory bowel disease,Crohns Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,674,1895,1.3623091349,0.7536762621,2.4624447821,1,0
Inflammatory bowel disease,Crohns Disease,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,515,132,4.2181680491,0.5373585084,33.111863703,1,0
Inflammatory bowel disease,Crohns Disease,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2723,688,1.0460508584,0.4531766638,2.4145603375,1,0
Inflammatory bowel disease,Crohns Disease,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,674,520,1.9367795577,0.770170949,4.8704966861,1,0
Inflammatory bowel disease,Crohns Disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,515,657,1.2149683539,0.5088598159,2.9008934385,1,0
Inflammatory bowel disease,Crohns Disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2723,2615,1.2078280104,0.7712054004,1.8916471562,1,0
Inflammatory bowel disease,Crohns Disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,674,1895,1.3648430528,0.7611306935,2.4474069625,1,0
Inflammatory bowel disease,Crohns Disease,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,515,132,4.1606341359,0.5258204396,32.921649883,1,0
Inflammatory bowel disease,Crohns Disease,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2723,688,1.0431324326,0.4488158935,2.4244356932,1,0
Inflammatory bowel disease,Crohns Disease,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,674,520,1.8572041693,0.7416761676,4.6505570451,1,0
Inflammatory bowel disease,Crohns Disease,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,515,657,1.2221848388,0.5119641984,2.9176567132,1,0
Inflammatory bowel disease,Crohns Disease,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2723,2615,1.2133897246,0.7751433842,1.8994093916,1,0
Inflammatory bowel disease,Crohns Disease,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,674,1895,1.3512262054,0.7535442127,2.4229663335,1,0
Inflammatory bowel disease,Crohns Disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,515,132,4.1361795462,0.519263911,32.946601675,1,0
Inflammatory bowel disease,Crohns Disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,2723,688,1.0208862057,0.4390374864,2.3738488794,1,0
Inflammatory bowel disease,Crohns Disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,674,520,1.9024773865,0.7670454312,4.7186516717,1,0
Inflammatory bowel disease,Crohns Disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,515,657,1.2280993924,0.5138386846,2.9352171464,1,0
Inflammatory bowel disease,Crohns Disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,2723,2615,1.226266955,0.7822393113,1.9223409297,1,0
Inflammatory bowel disease,Crohns Disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,674,1895,1.3492463286,0.747070342,2.436806219,1,0
Inflammatory bowel disease,Crohns Disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,515,132,4.1214598974,0.5222931916,32.522789803,1,0
Inflammatory bowel disease,Crohns Disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2723,688,1.0287521507,0.4398396671,2.4061744917,1,0
Inflammatory bowel disease,Crohns Disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,674,520,1.9878058526,0.8000949343,4.9386290778,1,0
Inflammatory bowel disease,Crohns Disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,515,657,1.2140237443,0.5074933274,2.9041833108,1,0
Inflammatory bowel disease,Crohns Disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2723,2615,1.1981155624,0.7657187348,1.8746843139,1,0
Inflammatory bowel disease,Crohns Disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,674,1895,1.344716047,0.7443974762,2.4291609053,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,526,137,107748.53528,43947.307134,264174.24894,0,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2778,705,1.1239889492,0.5200506768,2.429284711,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,680,519,1.5024708615,0.7298214818,3.0931107756,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,526,657,0.7689963463,0.2516798745,2.3496331672,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2778,2637,1.3065227082,0.8495500238,2.0093008525,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,680,1900,1.8974613609,1.1561156381,3.1141864165,1,1
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs DMARD,MPCD,526,137,58467.968881,21832.934678,156575.53304,0,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2778,705,0.7443628007,0.308059041,1.7986032068,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs DMARD,Medicare,680,519,1.6655747703,0.7713901447,3.5962856596,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,526,657,0.4807358087,0.1433788428,1.611862066,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2778,2637,1.1632854778,0.7263927516,1.8629496231,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,680,1900,1.8781829711,1.0679019251,3.3032726979,1,1
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,526,137,65068.770076,24133.082813,175441.52448,0,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2778,705,0.7395857451,0.3024424102,1.8085660471,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,680,519,1.7401885867,0.811806137,3.7302702939,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,526,657,0.4845203737,0.1445025423,1.624608044,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2778,2637,1.1835845276,0.7368104788,1.9012654873,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,680,1900,1.88049988,1.0585943085,3.340542992,1,1
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,526,137,58422.642737,21822.416707,156408.21226,0,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2778,705,0.7516327003,0.3109342412,1.8169491851,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,680,519,1.6851947643,0.7808686298,3.6368235133,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,526,657,0.4822521177,0.1436391987,1.6191061146,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2778,2637,1.1619794475,0.7258712636,1.8601042694,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,680,1900,1.8780282058,1.068031075,3.3023289531,1,1
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,526,137,58104.87622,21695.170437,155618.81159,0,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2778,705,0.7379040308,0.3051700661,1.7842587434,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,680,519,1.6310134703,0.7580139931,3.5094404119,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,526,657,0.4817248802,0.1436683928,1.6152394806,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2778,2637,1.165896072,0.7278237397,1.8676412662,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,680,1900,1.870755728,1.0647894242,3.2867785069,1,1
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,526,137,64707.970933,24012.370041,174373.52061,0,0
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,2778,705,0.7429454441,0.3039724106,1.8158487864,1,0
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,680,519,1.7289359671,0.8088771614,3.695517343,1,0
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,526,657,0.487222637,0.1450747564,1.6363005115,1,0
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,2778,2637,1.18778954,0.7386028307,1.9101524295,1,0
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,680,1900,1.8698401202,1.0545322088,3.3155005089,1,1
Inflammatory bowel disease,Ulcerative Colitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,526,137,66439.575622,24611.99754,179352.25297,0,0
Inflammatory bowel disease,Ulcerative Colitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2778,705,0.748323447,0.3056209289,1.8322959205,1,0
Inflammatory bowel disease,Ulcerative Colitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,680,519,1.7676296282,0.8226299414,3.7982017733,1,0
Inflammatory bowel disease,Ulcerative Colitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,526,657,0.4781076459,0.1425493324,1.6035636034,1,0
Inflammatory bowel disease,Ulcerative Colitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2778,2637,1.1646069434,0.7269402782,1.8657782124,1,0
Inflammatory bowel disease,Ulcerative Colitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,680,1900,1.8620749605,1.0490769698,3.3051179833,1,1
Kidney disease,Amyloidosis,"a Weighted, no covariates",TNF vs DMARD,MPCD,537,139,2.2138649056,0.1568091338,31.25581847,1,0
Kidney disease,Amyloidosis,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2819,710,11983963.312,1621393.2517,88575289.509,0,0
Kidney disease,Amyloidosis,"a Weighted, no covariates",TNF vs DMARD,Medicare,702,537,3167743.4063,455053.75248,22051457.071,0,0
Kidney disease,Amyloidosis,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,1.6510327E-8,9.388548E-10,2.9034406E-7,0,0
Kidney disease,Amyloidosis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2819,2651,7309439.7471,1000917.4469,53378937.078,0,0
Kidney disease,Amyloidosis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,702,1920,0.3147931824,0.0368822043,2.6867902734,1,0
